Abstract:Background: Autogenous bone graft is the gold standard bone grafting substrate available in spinal fusion because of its osteoconductive, osteogenic, and osteoinductive properties. However, several shortcomings including bleeding, infection, chronic pain, and nerve injury are known to be associated with the procedure. Bone tissue engineering has emerged as an alternative therapeutic strategy for bone grafts. New materials have been developed and tested that can substitute for the autogenous bone grafts used in the spinal fusion. The purpose of this study is to evaluate the role of a novel tissue-engineered bone graft with silicon-substituted calcium phosphate (Si-CaP), autogenous fine particulate bone powder (AFPBP), and bone marrow mesenchymal stem cells (BMSCs) using a rabbit posterolateral lumbar fusion model based on bone tissue engineering principles. The application of this graft can represent a novel choice for autogenous bone to reduce the amount of autogenous bone and promote spinal fusion. Methods: BMSCs from New Zealand white rabbits were isolated and cultured in vitro. Then, BMSCs were marked by the cell tracker chloromethyl-benzamidodialkylcarbocyanine (CM-Dil). A total of 96 New Zealand White rabbits were randomly divided into four groups: (a) AFPBP, (b) Si-CaP, (c) Si-CaP/AFPBP, (d) Si-CaP/AFPBP/ BMSCs.The rabbits underwent bilateral posterolateral spine arthrodesis of the L5-L6 intertransverse processes using different grafts. Spinal fusion and bone formation were evaluated at 4, 8, and 12 weeks after surgery by manual palpation, radiology, micro-computed tomography (micro-CT), histology, and scanning electronic microscopy (SEM). Results: The rate of fusion by manual palpation was higher in the Si-CaP/AFPBP/BMSCs group than the other groups at 8 weeks. The fusion rates in the Si-CaP/AFPBP/BMSCs and the AFPBP groups both reached 100%, which was higher than the Si-CaP/AFPBP group (62.5%) (P > 0.05). No difference in bone volume was observed between the Si-CaP/AFPBP/BMSCs group (44.39%) and AFPBP group (45.06%) at 12 weeks (P < 0.05). At 12 weeks, new trabecular were visible in the Si-CaP/AFPBP/BMSCs group by SEM. CM-Dil-positive cells were observed at all stages. Compared with histological images, BMSCs participate in various stages of osteogenesis by transforming into osteoblasts, chondrocytes, and osteocytes. Conclusion: This study demonstrated for the first time that Si-CaP/AFPBP/BMSCs is a novel tissue-engineered bone graft with excellent bioactivity, biocompatibility, and biodegradability. The graft could reduce the amount of autogenous bone and promote spinal fusion in a rabbit posterolateral lumbar fusion model, representing a novel alternative to autogenous bone. The Translational potential of this article: The translational potential of this article lies in that this graft will be a novel spinal fusion graft with great potential for clinical applications.

The Primary Report of Clinical Application of Enriched Bone Marrow Stem Cells Combining with Β-Tricalcium Phosphate in Spine Fusion

The Clinical Use of Enriched Bone Marrow Stem Cells Combined with Porous Beta-Tricalcium Phosphate in Posterior Spinal Fusion

Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material

Bone marrow mesenchymal stem cells loaded β-tricalcium phosphate promote lumbar intervertebral fusion: a randomized controlled clinical trial

Bone regeneration study by new bioactive composite material-Bone marrow stem cells combining with porous tricalcium phosphate

Nano-hydroxyapatite Coated Biphasic Calcium Phosphate for Posterolateral Lumbar Fusion：combined Magnetic Field Plays an Auxiliary Role

Enrichment of bone marrow stromal stem cells for lumbar intertransverse spinal fusion of rabbits

Bone barrow mesenchymal stem cells in conjunction with bone morphOgenetic protein promote spine interbody fusion in rabbits

Effects of a bone graft substitute consisting of porous gradient HA/ZrO 2 and gelatin/chitosan slow-release hydrogel containing BMP-2 and BMSCs on lumbar vertebral defect repair in rhesus monkey.

Construction of calcium sulfate/bone marrow mesenchymal stem cells tissue-engineered bone for spinal fusion

Anterior Lumbar Interbody Fusion with Carbon Fiber Cage Loaded with Bioceramics and Platelet-Rich Plasma. an Experimental Study on Pigs

A Novel Tissue-Engineered Bone Graft Composed of Silicon-Substituted Calcium Phosphate, Autogenous Fine Particulate Bone Powder and BMSCs Promotes Posterolateral Spinal Fusion in Rabbits

P84. Bone Marrow Aspirate with or Without Platelet Concentrates As a Bone Graft Substitute for Posterolateral Spinal Fusion: A Randomized, Controlled Study Using an Animal Model

The clinical study on the application of calcium sulfate/DBM granule to enhance the instrumented lumbar spine posterolateral fusion

Effects of Combined Magnetic Fields Treatment and Nano-Hydroxyapatite Coating on Porous Biphasic Calcium Phosphate Bone Graft in Rabbit Spinal Fusion Model.

Improved Posterolateral Lumbar Spinal Fusion Using a Biomimetic, Nanocomposite Scaffold Augmented by Autologous Platelet-Rich Plasma

Tissue-engineered Bone Used in a Rabbit Model of Lumbar Intertransverse Process Fusion: A Comparison of Osteogenic Capacity Between Two Different Stem Cells

Single-Level Instrumented Posterolateral Fusion of Lumbar Spine With β-Tricalcium Phosphate Versus Autograft

Application of bone repair materials containing recombinant human bone morphogenetic protein-2 in anterior cervical discectomy and fusion

Intervertebral Spinal Fusion Using A Rp-Based Plga/Tcp/Bbmp Biomimetic Grafting Material

Experimental study on lumbar interbody fusion with silk fibroin enhanced calcium phosphate cement composite loaded with recombinant human bone morphogenetic protein-2 in sheep